Please select a Capability in order to start your service request.
IHE Connectathon Provides Opportunity to Test, Validate Standards-Based Interoperability FunctionalityFeb 25, 2015
February 25, 2015 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced it participated in the Integrating the Healthcare Enterprise (IHE) Connectathon at the HIMSS Innovation Center with the goal of renewing certifications for four separate Patient Care Device (PCD) interoperability standards associated with its Alaris® System smart infusion platform.
CareFusion tested for renewal of certifications for Point of Care Infusion Verification (PIV), Infusion Pump Event Communication (IPEC), Device Enterprise Communication (DEC) and Alarm Communication Management (ACM) at the 2015 IHE Connectathon, that was held Jan. 26-30 in Cleveland. CareFusion is the only company that currently has live customer sites performing bi-directional interoperability with electronic medical records (EMRs) for both large volume pumps and syringe pumps.
“As a leader in interoperability, it is important that our customers know that our infusion systems are certified with a standards-based approach to interfacing with other health care IT systems,” said JC Kyrillos, senior vice president and general manager of Infusion Technologies for CareFusion. “With nine sites already live with our interoperability solutions, it is clear that the future of medical devices is reliant on communication with other health care IT systems.”
Alaris EMR interoperability delivers on true electronic medical record interoperability by offering seamless two-way connectivity between the Alaris System and leading HIT systems. Alaris EMR interoperability closes the loop on computerized physician order entry (CPOE), barcode medication administration (BCMA) and infusion pumps—with just one additional scan. This eliminates manual programming that creates risk of IV medication errors, while extending safety to infusion administration. It also automates documentation back to the EMR to save valuable clinician time and helps ensure accurate infusion data in the patient record.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com
For more information on BD, please visit bd.com.